ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,917Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 890

$721K Total Retail Price of All Prescriptions

Rank: 133 out of 890

394 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 394 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

27% of this provider’s 394 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 9,027 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 531 281 S3 1 3
FUROSEMIDE 457 335 2 7
POTASSIUM CHLORIDE 367 273 3 11
SIMVASTATIN 340 267 4 5
LEVOTHYROXINE SODIUM 284 218 5 2
OMEPRAZOLE 254 195 6 8
METFORMIN HCL 231 153 7 6
NAMENDA 228 214 8 36
MELOXICAM 225 181 9 18
DONEPEZIL HCL 213 201 10 30
AMLODIPINE BESYLATE 210 122 11 1
CARVEDILOL 197 167 12 22
ATORVASTATIN CALCIUM 166 111 13 13
NEXIUM 162 125 14 14
PREDNISONE 154 85 15 47
RANITIDINE HCL 149 114 16 49
CLOPIDOGREL 148 116 17 28
LISINOPRIL 138 95 18 4
ZOLPIDEM TARTRATE 135 107 19 19
METOPROLOL TARTRATE 133 108 20 15
GABAPENTIN 131 100 21 12
WARFARIN SODIUM 131 115 21 24
ACTOS 128 113 23 88
DIOVAN 128 65 23 33
GLIMEPIRIDE 122 87 25 27
HYDROCHLOROTHIAZIDE 121 79 26 9
METOPROLOL SUCCINATE 120 78 27 17
ESCITALOPRAM OXALATE 112 84 28 51
DIOVAN HCT 112 96 28 48
AMLODIPINE BESYLATE-BENAZEPRIL 111 81 30 41
ISOSORBIDE MONONITRATE ER 106 90 31 60
JANUVIA 105 73 32 59
TERAZOSIN HCL 102 97 33 142
CLEMASTINE FUMARATE 102 65 R 33 231
CYCLOBENZAPRINE HCL 100 51 R 35 64
AMITRIPTYLINE HCL 100 82 R 35 43
PLAVIX 99 77 37 42
SINGULAIR 98 52 38 79
CEFUROXIME 97 50 39 168
CITALOPRAM HBR 94 73 40 20
CIPROFLOXACIN HCL 92 54 41 58
ALLOPURINOL 90 53 42 31
RISPERIDONE 90 77 42 78
SPIRONOLACTONE 88 66 44 85
HYDRALAZINE HCL 87 28 45 100
ZETIA 87 56 45 81
NIFEDIPINE ER 86 86 47 75
LYRICA 86 51 47 71
CRESTOR 86 73 47 25
PANTOPRAZOLE SODIUM 85 56 50 34
MONTELUKAST SODIUM 79 42 51 130
LANTUS 78 49 52 50
AZITHROMYCIN 77 47 53 37
DIGOXIN 71 63 54 65
FENTANYL 68 46 S2 55 151
TRAMADOL HCL 68 65 55 16
LACTULOSE 68 44 55 112
SERTRALINE HCL 68 46 55 26
CLONIDINE HCL 68 60 55 35
KLOR-CON M20 66 44 60 72
LIPITOR 66 36 60 77
FLUCONAZOLE 65 43 62 155
ARICEPT 63 62 63 408
PROAIR HFA 63 19 63 55
LEVETIRACETAM 62 25 65 137
PRAVASTATIN SODIUM 59 44 66 10
ZIPRASIDONE HCL 58 37 67 229
BYSTOLIC 56 24 68 86
TRAZODONE HCL 55 13 69 40
ALBUTEROL SULFATE 54 54 70 162
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 27 70 76
OXCARBAZEPINE 53 38 72 316
DICLOFENAC SODIUM 52 29 73 96
PIOGLITAZONE HCL 51 42 R 74 211
DOXYCYCLINE HYCLATE 50 32 75 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.